Validation of Boolean 2.0 criteria for remission and quality of life prediction in Korean patients with rheumatoid arthritis receiving targeted therapy
Although Boolean 2.0 improves concordance with DAS28-ESR, it does not enhance the prediction of long-term functional or QoL outcomes. Its broader definition of remission warrants cautious interpretation in clinical practice.
Authors
- Soo‐Kyung Cho (ORCID: https://orcid.org/0000-0003-4493-8837)
- Eunwoo Nam (ORCID: https://orcid.org/0000-0001-5175-7095)
- Se Rim Choi (ORCID: https://orcid.org/0000-0002-4625-8571)
- Yoon‐Kyoung Sung (ORCID: https://orcid.org/0000-0001-6691-8939)
Institutions
- Institute for Rheumatic Diseases (Japan) (JP)
- Hanyang University Seoul Hospital (KR)
- Hanyang University (KR)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-09-28
- DOI
- https://doi.org/10.1093/rheumatology/keaf516
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00